Health Care/Hospital
LIMACORPORATE'S ADVANCED TESTING FACILITY RECEIVES ISO 17025 CERTIFICATION BY ACCREDIA
UDINE, Italy, Feb. 16, 2022 /PRNewswire/ -- LimaCorporate is proud to announce the ISO 17025 accreditation by Accredia. This important achievement covers the activities of ATLAs, the company's Advanced Laboratory for Testing and Analysis. ATLAs is the core of the experimental verification and sim...
2022-02-16 21:00
2246
JIXING ANNOUNCES RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR AFICAMTEN IN CHINA
SHANGHAI, Feb. 16, 2022 /PRNewswire/ -- Ji Xing Pharmaceuticals Limited (JIXING), a clinical-stage biopharmaceutical company committed to bringing innovative medicines to underserved Chinese patients with serious and life-threatening diseases, today announced that the Center for Drug Evaluation ...
2022-02-16 18:06
2185
Sirnaomics Receives Safe to Proceed Letter for U.S. FDA Investigational New Drug Application for Systemic RNAi Therapeutic STP707 in Primary Sclerosing Cholangitis (PSC)
HONG KONG, Feb. 16, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or " Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that they have received the "safe to proceed" letter from the U.S. Food and Drug Adminis...
2022-02-16 17:04
2699
Nippon Express (China) Donates Protective Suits to China Railway Express Terminal Station in Xi'an
TOKYO, Feb. 16, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NX China"), a Nippon Express Holdings, Inc. Group company, has donated protective suits to the Xi'an International Inland Port Investment & Development Group (hereinafter "ITL Group") operating the rail terminal i...
2022-02-16 15:00
1941
NIBIOHN, Shionogi Discover Host Immune-dependent Novel Anti-coronavirus Antibody
OSAKA, Japan, Feb. 16, 2022 /PRNewswire/ -- The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN;Ibaraki-shi, Osaka; Director-general:Yoshihiro Yoneda), in partnership with Shionogi & Co., Ltd. (Chuo-ku,Osaka; President and CEO: Isao Teshirogi), has successfully identif...
2022-02-16 14:00
1935
A Breakthrough in Probiotic Therapy - Personalized Probiotics (Dispensing) Machine for a Balanced and Enhanced Immune System
BANGKOK, Feb. 16, 2022 /PRNewswire/ -- MED-CU has invented a Personalized
Probiotics (Dispensing) Machine to deliver live microorganisms that have health
benefits to treat patients with unclear health problems and those with
microbial imbalances or "dysbiosis".
2022-02-16 10:00
1827
Delos Capital Announces $300 Million First Close of its Third Life Sciences Fund
HONG KONG, Feb. 15, 2022 /PRNewswire/ -- Delos Capital, a Hong Kong -headquartered life sciences venture capital fund with a global presence and investment mandate, announces the successful$300 million first close of its Fund III. The first close of Fund III was completed in only 6 months of fun...
2022-02-15 23:59
2296
Goodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive Officer
PLANTATION, Fla., Feb. 15, 2022 /PRNewswire/ -- Goodwin Biotechnology, Inc. is pleased to announce a key appointment designed to accelerate its growth significantly and scale the company into the future.Darrin Schellin joins the company as Chief Executive Officer and will also be inducted as a me...
2022-02-15 22:35
2006
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team
PRINCETON, N.J. and SINGAPORE, Feb. 15, 2022 /PRNewswire/ -- Travecta Therapeutics, Pte Ltd., a preclinical stage biopharmaceutical company pioneering a portfolio of product candidates engineered to cross the blood-brain-barrier, today announced significant expansion of the Scientific Advisory B...
2022-02-15 21:00
1816
HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg)
TOKYO, Feb. 15, 2022 /PRNewswire/ -- HPG Co., Ltd. (Chuo-ku, Tokyo) has successfully developed a water-soluble formulation technology of highly concentrated catechin EGCg (Epigallocatechin gallate) with excellent storage stability and initiated procedures for a patent application for the technol...
2022-02-15 16:00
1948
AIA ANNOUNCES 'AMPLIFY HEALTH' - A NEW HEALTH INSURTECH BUSINESS IN PARTNERSHIP WITH DISCOVERY GROUP
* New digital health technology and integrated solutions business that will deploy a range of health technology assets, proprietary data analytics and extensive health expertise. * Accelerates AIA's Health & Wellness strategy and positions the Group to capture significant new opportunities ...
2022-02-15 15:40
4558
Recbio Provides Updates on First Lyophilized mRNA Vaccine and Pre-clinical Data Showing Long-term stability and Strong immunogenicity against SARS-CoV-2
TAIZHOU, China, Feb. 15, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (Recbio), aChina-based company focused on the development of innovative vaccines for major diseases, announced preclinical data of its subsidiary Wuhan Recogen Biotechnology Co., Ltd. (Recogen) on lyophilized mRN...
2022-02-15 12:57
2444
G-NiiB probiotics - world's first microbiome-based immunity formulas now available at IMI
HONG KONG, Feb. 15, 2022 /PRNewswire/ -- IMI - Integrated Medicine Institute, Asia's largest natural health clinic, is pleased to announce the availability of G-NiiB Immunity Proand G-NiiB Immunity Plus probiotic formulas designed to tackle gut bacterial imbalances (dysbiosis) - a widespread healt...
2022-02-15 09:30
2664
Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine
Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Singapore GAITHERSBURG, Md., Feb. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, toda...
2022-02-15 05:02
2079
Mentice Appoints Jan Grund Pedersen as New VP of Strategic Alliances & Business Development
STOCKHOLM, Feb. 15, 2022 /PRNewswire/ -- Mentice, a world leader in simulation solutions for image-guided interventional therapies, today announced the appointment ofJan Grund Pedersen as the Vice President for Strategic Alliances & Business Development. Jan possesses over twenty-five years of ...
2022-02-15 00:50
1754
New year, New Beginning: Chemaxon announces new CEO, Richard Jones
BUDAPEST, Hungary, Feb. 14, 2022 /PRNewswire/ -- Chemaxon, a leader in
cheminformatics software development for life science research, announced the
appointment ofRichard Jones as Chief Executive Officer (CEO). Richard follows
ownerFerenc (Csizi) Csizmadia in the position.
2022-02-14 21:00
2513
Elekta announces preliminary third quarter results
STOCKHOLM, Feb. 14, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) today published preliminary financial results for the third quarter 2021/22. The demand for Elekta's precision radiation medicine solutions continued to be strong in the quarter, driven byEurope and recovery in several emerging markets ...
2022-02-14 20:51
1921
Shanghai Public Health Clinical Center Initiated Functional Cure Study of Anti-PD-L1 Antibody ASC22 (Envafolimab) in Combination With Chidamide in HIV-Infected Patients
HANGZHOU, China and SHAOXING, China, Feb. 14, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that Shanghai Public Health Clinical Center initiated functional cure study of anti-PD-L1 antibody ASC22 (Envafolimab) in combination with Chidamide in patients infected by human ...
2022-02-14 17:34
2860
Establishment of RMB 60 Billion Industry Fund in Chengdu Hi-tech Industrial Development Zone Sincere Invitation of Professional Institutional Investors for Cooperation
CHENGDU, China, Feb. 14, 2022 /PRNewswire/ -- On February 8, the business environment improvement conference was held in Chengdu Hi-tech Industrial Development Zone, clarifying that the industry fund ofRMB 60 billion will be established this year and that the industrial development "partners" wil...
2022-02-14 16:58
2448
Clinical trials in Russia and Azerbaijan demonstrated safety of AstraZeneca and Sputnik Light vaccines combination
MOSCOW, Feb. 14, 2022 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate the safety and immunogenicity of the combined use of AstraZeneca's vaccine and the first ...
2022-02-14 16:00
1870
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 282 media titles]
2024-04-18 21:26
Animated Life in Yunnan
[Picked up by 278 media titles]
2024-04-18 14:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 277 media titles]
2024-04-19 13:25
Most Read
Sephora appoints Xia Ding as Managing Director of Sephora Greater China
2024-04-15 17:33
3819
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
3618
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
2024-04-15 08:00
3085
Goldpac Exhibits at InnoEx 2024
2024-04-13 10:00
3023